Start free

Assembly Biosciences, Inc. (ASMB) insider trading

Recent insider transactions reported to the SEC on Form 4 — directors and officers buying or selling their own company’s stock. Sourced directly from public SEC filings, latest filed Nov 3, 2026.

Filings shown
18
Open-market buys
0
Open-market sells
9

Counts cover the 18 most recent Form 4 filings Tradune holds for ASMB (filed May 27 – Nov 3, 2026); the score below covers only the trailing 90 days (0 buys, 8 sells). SEC EDGAR Form 4 filings for ASMB last checked Nov 21, 2026, 09:00 UTC; the latest ASMB filing Tradune holds was filed Nov 3, 2026. This is not guaranteed to be the complete record — see ASMB's full Form 4 filing history on SEC EDGAR.

Open-market activity, last 90 days

Purchases (Form 4 code P) and sales (code S) on the 5 filings Tradune holds for ASMB filed Nov 3, 2026. Grants, exercises, tax withholding and the other Form 4 transaction codes are left out.

8 open-market sales by Rule 10b5-1 checkbox

On filings with the 10b5-1 box checked
0 sales· 0 sh
checkbox disclosed
On filings with the box not checked
8 sales· 12,115 sh
not proof that no plan exists
Not comparable
0 sales· 0 sh
filed before Apr 1, 2023, or no checkbox value in the filing data

Counts are Form 4 lines as filed. The checkbox is one per filing, so every sale on a filing with the box checked is counted there even if only some of its transactions were under a plan; it records what the filer disclosed, and the three categories are not a judgement about why a sale was made.

Open-market purchases and sales by insider
Insider Buys Sells Shares bought Shares sold Value
Jason A. OkazakiCEO and President 0 2 — 6,202 −$121,658
Anuj GaggarChief Medical Officer 0 2 — 2,593 −$50,864
Nicole S. WhiteChief Manufacturing Officer 0 2 — 2,593 −$50,864
Jeanette M. BjorkquistPFO and PAO 0 2 — 727 −$14,261

Value = shares × the price reported on each Form 4 (+ purchases, − sales); every open-market line in this window disclosed a price.

Insider-activity score

0/ 100

Net insider sales
0 distinct buyers0 buy · 8 sell tx

Summarises ~90 days of public SEC Form 4 activity — more distinct buyers, officer involvement and net buying score higher. A description of filing activity, not a rating or buy signal. How this score is computed →

Get alerted when insiders buy the stocks you own

Add your holdings — no brokerage login — and Insider Radar sends a Telegram alert when an open-market Form 4 buy of $100,000 or more is filed on a stock you hold or watch.

Free for everyone right now · no card · nothing to buy

Start free

How to read this: an open-market purchase (Form 4 code P) is a buy at the market price with the insider’s own money, as opposed to a grant, award or option exercise; an open-market sale is code S. When two or more distinct insiders report open-market purchases in the same 90-day window, this site labels that a cluster — a definition, not a forecast; see insider cluster buying. “Held after” is Form 4 Table I column 5; “Change” = shares ÷ holdings before the trade (held after − shares for an acquisition, held after + shares for a disposition).

Insider Buying at ASMB

No open-market insider purchases (Form 4 code P) were reported for ASMB between May 27, 2026 and Nov 3, 2026. The filings below may include other transaction types — sales, grants, option exercises, and tax withholding — shown for completeness; they are not open-market purchases.

Recent Form 4 filings

Source: SEC EDGAR Form 4 · transaction codes explained

Jeanette M. Bjorkquist PFO and PAO · filed Nov 3, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box not checked 9 $20.35 17,673 −0.1% Nov 2, 2026
Open-market sale 10b5-1 box not checked 718 $19.61 17,682 −3.9% Nov 2, 2026
Grant / award 3,840 — 18,400 +26% Oct 30, 2026

† change in this filer’s own reported holding line (Form 4 Table I, col. 5), not of total company ownership; small prior holdings produce large percentages, so under 100 shares the prior holding is shown instead.

“10b5-1 box checked” = the filer checked the Form 4 box stating that a transaction on the filing was made under a plan intended to satisfy Rule 10b5-1(c); “10b5-1 box not checked” = the box was left blank, which does not prove that no plan exists. The box applies to Form 4s filed from April 1, 2023; older filings, and boxes we could not read, carry no tag. What the 10b5-1 box means.

Nicole S. White Chief Manufacturing Officer · filed Nov 3, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box not checked 2,564 $19.61 59,286 −4.1% Nov 2, 2026
Open-market sale 10b5-1 box not checked 29 $20.35 59,257 −0.0% Nov 2, 2026
Grant / award 13,705 — 61,850 +28% Oct 30, 2026
Anuj Gaggar Chief Medical Officer · filed Nov 3, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box not checked 2,564 $19.61 53,829 −4.5% Nov 2, 2026
Open-market sale 10b5-1 box not checked 29 $20.35 53,800 −0.1% Nov 2, 2026
Grant / award 13,705 — 56,393 +32% Oct 30, 2026
Jason A. Okazaki CEO and President · filed Nov 3, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box not checked 6,133 $19.61 195,601 −3.0% Nov 2, 2026
Open-market sale 10b5-1 box not checked 69 $20.35 195,532 −0.0% Nov 2, 2026
Grant / award 38,380 — 201,734 +23% Oct 30, 2026
William E. Delaney IV Chief Scientific Officer · filed Nov 3, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 13,705 — 74,035 +23% Oct 30, 2026
Jeanette M. Bjorkquist PFO and PAO · filed Jun 18, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box not checked 29 $23.25 14,560 −0.2% Jun 17, 2026
John G. McHutchison Director · filed Jun 5, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Stock Option (right to buy) 8,000 — — — Jun 4, 2026
Susan Mahony Director · filed Jun 5, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Stock Option (right to buy) 8,000 — — — Jun 4, 2026
Lisa Johnson-Pratt Director · filed Jun 5, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Stock Option (right to buy) 8,000 — — — Jun 4, 2026
Michael Houghton Director · filed Jun 5, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Stock Option (right to buy) 8,000 — — — Jun 4, 2026
Gina Consylman Director · filed Jun 5, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Stock Option (right to buy) 8,000 — — — Jun 4, 2026
Anthony E. Altig Director · filed Jun 5, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Stock Option (right to buy) 8,000 — — — Jun 4, 2026
Anuj Gaggar Chief Medical Officer · filed Jun 5, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 14,000 — 42,688 +49% Mar 29, 2026
Nicole S. White Chief Manufacturing Officer · filed Jun 5, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 14,000 — 48,145 +41% Mar 29, 2026
Jeanette M. Bjorkquist PFO and PAO · filed Jun 5, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 3,500 — 14,589 +32% Mar 29, 2026
William E. Delaney IV Chief Scientific Officer · filed Jun 5, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 14,000 — 60,330 +30% Mar 29, 2026
Jason A. Okazaki CEO and President · filed Jun 5, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 50,750 — 163,354 +45% Mar 29, 2026
Gilead Sciences, Inc. 10% owner · filed May 27, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 471,698 $26.50 4,977,089 +10% May 26, 2026

Insider filings reported around the same time

Other companies whose most recent Form 4 was filed closest to ASMB's (Nov 3, 2026).

Frequently asked about ASMB insider activity

How many insiders bought ASMB stock in these Form 4 filings?

No open-market purchases (Form 4 code P) of ASMB shares were reported by Assembly Biosciences, Inc. insiders between May 27, 2026 and Nov 3, 2026. The 18 filings shown on this page cover other transaction types — sales, grants, option exercises, and tax withholding.

Who filed the most recent Form 4 for ASMB?

The most recent Form 4 on this page was filed by William E. Delaney IV (Chief Scientific Officer) on Nov 3, 2026, reporting 1 transaction. The original document is linked from the filing list above on SEC EDGAR. Amended filings (Form 4/A) may later revise reported figures.

What was the largest open-market ASMB insider sale shown?

The largest open-market sale among the filings shown was 6,133 ASMB shares at $19.61 (about $120,254) by Jason A. Okazaki (CEO and President) on Nov 2, 2026. Value is shares × the price reported on the Form 4; its Rule 10b5-1 box is not checked.

New to Form 4s? The transaction codes, the 90-day window and the 0–100 score are defined on the insider-activity score methodology page.

Get insider alerts for ASMB — and your whole portfolio

Tradune watches SEC Form 4 filings and flags insider-cluster buying across everything you hold, routed to you automatically. Free for everyone right now · no card · nothing to buy

This score summarizes SEC Form 4 filing activity over the trailing 90 days. It is descriptive, not predictive — not a rating, recommendation, or investment advice. Data: SEC EDGAR (public domain), as filed; amendments may revise figures. Tradune is not a registered investment adviser.

Data as filed; amended filings (Form 4/A) may revise figures. Sales may occur under prearranged Rule 10b5-1 trading plans.